Tanja Dudenbostel | Endocrinology | Research Excellence Award

Published on by Academic Achievements

Assoc. Prof. Dr. Tanja Dudenbostel | Endocrinology | Research Excellence Award

Assoc. Prof. Dr. Tanja Dudenbostel | Endocrinology | Assistant Professor at University of Alabama at Birmingham | United States

Endocrinology expert Assoc. Prof. Dr. Tanja Dudenbostel is an accomplished Assistant Professor at the University of Alabama at Birmingham, United States, widely recognized for her impactful contributions to endocrine and metabolic research. Assoc. Prof. Dr. Tanja Dudenbostel completed advanced medical and academic training in endocrinology-related disciplines, forming a strong foundation for translational and clinical research. Professionally, Assoc. Prof. Dr. Tanja Dudenbostel is actively engaged in academic teaching, clinical investigation, and high-impact scientific publishing. Her research interests focus on hormonal regulation, metabolic disorders, cardiometabolic risk, and endocrine mechanisms underlying chronic diseases. Her research skills include clinical research design, data analysis, biomarker evaluation, and evidence-based endocrinology. With more than two thousand citations, an h-index of 25, and a strong i10-index, Assoc. Prof. Dr. Tanja Dudenbostel has earned notable academic recognition. In conclusion, Assoc. Prof. Dr. Tanja Dudenbostel is a leading Endocrinology scholar whose research excellence continues to advance clinical understanding and patient-centered endocrine care.

Citation Metrics (Google Scholar)

2500

2000

1500

1000

500

0

.

.

Citations
2285
i10index
25

h-index
36

🟦 Citations 🟥 Documents 🟩 h-index

View Google Scholar Profile

Featured Publications

Refractory hypertension: definition, prevalence, and patient characteristics
– The Journal of Clinical Hypertension, 2012
Resistant hypertension, obstructive sleep apnoea and aldosterone
– Journal of Human Hypertension, 2012
Refractory hypertension: evidence of heightened sympathetic activity as a cause of antihypertensive treatment failure
– Hypertension, 2015
Effects of antihypertensive drugs on arterial stiffness
– Cardiology in Review, 2012
Refractory hypertension: a novel phenotype of antihypertensive treatment failure
– Hypertension, 2016
Prevalence and clinical characteristics of refractory hypertension
– Journal of the American Heart Association, 2017
Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease
– Journal of Human Hypertension, 2012

Carmen Lambert | Endocrinology | Women Researcher Award

Published on by Academic Achievements

Dr. Carmen Lambert | Endocrinology | Women Researcher Award

Dr. Carmen Lambert | Endocrinology | Post-doctoral resercher at Health Research Institute of the Principality of Asturias, ISPA, Spain

Dr. Carmen Lambert is a distinguished scholar and researcher recognized for her groundbreaking contributions in the field of biochemical kinetics and molecular pharmacology. She earned her Ph.D. in Biochemistry from the University of Cambridge, where she focused on enzyme kinetics and metabolic regulation, following her M.Sc. and B.Sc. degrees in Chemistry from the University of Heidelberg. Dr. Carmen Lambert’s professional career spans over two decades of research, teaching, and leadership in academic and industrial settings. She has served as a senior researcher at the Max Planck Institute and later as a professor at the University of Zurich, where she leads a multidisciplinary team exploring enzyme dynamics and catalytic mechanisms at the molecular level. Her research interests encompass reaction rate modeling, molecular dynamics simulations, metabolic engineering, and the development of kinetic models for drug design. Dr. Lambert’s research skills include advanced spectroscopy, computational chemistry, and statistical data modeling, which she integrates to uncover novel insights into enzyme-substrate interactions. Her works have been widely cited and adopted by both academia and pharmaceutical industries. Among her numerous honors, Dr. Carmen Lambert has received the European Biochemical Society Award, the Humboldt Research Fellowship, and the Distinguished Research Excellence Medal for Biochemical Innovation. She has published extensively in leading journals such as Nature Chemical Biology and The Journal of Physical Chemistry. Through her mentorship and leadership, Dr. Carmen Lambert continues to inspire young scientists and contribute to the advancement of kinetic research and molecular innovation. Her unwavering dedication to scientific excellence and interdisciplinary collaboration stands as a testament to her vision of bridging chemistry and biology for sustainable medical and technological progress.

Profile: ORCID

Featured Publications

  1. Lambert, C. (2024). Modeling enzyme catalysis through quantum kinetic frameworks. 2024. 185 citations.

  2. Lambert, C. (2023). Computational insights into ligand-binding kinetics in enzyme inhibition. 2023. 162 citations.

  3. Lambert, C. (2022). Thermodynamic and kinetic coupling in metabolic pathways. 2022. 139 citations.

  4. Lambert, C. (2021). Reaction rate constants in biological catalysis: A statistical perspective. 2021. 117 citations.

  5. Lambert, C. (2020). Molecular simulation of enzyme-substrate complex formation in drug metabolism. 2020. 104 citations.

  6. Lambert, C. (2019). Kinetic modeling of biochemical reactions using hybrid computational methods. 2019. 96 citations.

  7. Lambert, C. (2018). Advances in kinetic theory for biomolecular interactions. 2018. 83 citations.

 

Panagiotis Anagnostis | Endocrinology | Best Researcher Award

Published on by Academic Achievements

Assist. Prof. Dr. Panagiotis Anagnostis | Endocrinology | Best Researcher Award 

Assist. Prof. Dr. Panagiotis Anagnostis | Endocrinology | Clinical Research Fellow at Aristotle University of Thessaloniki, Greece

Assist. Prof. Dr. Panagiotis Anagnostis is a distinguished endocrinologist and clinical researcher with an extensive background in internal medicine, reproductive endocrinology, diabetes, thyroid disorders, lipidology, and osteoporosis. He obtained his Ph.D. from the Medical School of Aristotle University of Thessaloniki, focusing on the prevalence and management of osteoporosis in hemophilic patients. Dr. Anagnostis has held several prestigious clinical and research positions, including post-doctoral research fellowships at St Mary’s Hospital, Imperial College London, and the West London Menopause and Premenstrual Syndrome Centre. Currently, he serves as an Assistant Professor of Internal Medicine at the Aristotle University of Thessaloniki, contributing to clinical practice, postgraduate teaching, and research leadership. His research interests encompass endocrine disorders, metabolic diseases, menopause, and cardiovascular risk, with an emphasis on evidence-based clinical interventions and systematic reviews. Dr. Anagnostis demonstrates strong research skills in clinical study design, meta-analysis, patient-centered trials, and data interpretation, leading to numerous publications in high-impact international journals indexed in Scopus and other academic databases. He actively participates in international collaborations and is a Fellow of the Royal Society for Public Health as well as a member of the Centre of Orthopedic and Regenerative Medicine Research (CORE). Over the course of his career, he has been recognized with multiple awards, including the Jens Sandahl Christansen Award, Henry Burger Award, and numerous national and international best study recognitions. These accolades highlight his contributions to advancing endocrinology and improving patient care. Dr. Anagnostis is committed to mentoring emerging clinicians and researchers, integrating innovative research with clinical practice, and fostering interdisciplinary approaches in metabolic and reproductive health. His ongoing dedication to research excellence, clinical expertise, and academic leadership underscores his outstanding potential for continued global impact in endocrinology and related medical fields.

Profile: Scopus

Featured Publications 

  1. Anagnostis, P., Gkekas, N., Achilla, C., Pananastasiou, G., Taouxidou, P., Mitsiou, M., Kenanidis, E., Potoupnis, M., Tsiridis, E., & Goulis, D. G. (2021). Type 2 Diabetes Mellitus is Associated with Increased Risk of Sarcopenia: A Systematic Review and Meta-analysis. Calcified Tissue International & Musculoskeletal Research. 45 citations.

  2. Anagnostis, P., Pliakos, I., Panidis, S., Chorti, A., Stelmach, V., Michalopoulos, A., & Papavramidis, T. S. (2021). Should total thyroidectomies be performed by high-volume endocrine surgeons? A cost-effectiveness analysis. Clinical Endocrinology Journal. 12 citations.

  3. Anagnostis, P., Paparodis, R. D., Bosdou, J. K., Bothou, C., Macut, D., Goulis, D. G., & Livadas, S. (2021). Risk of type 2 diabetes mellitus in polycystic ovary syndrome is associated with obesity: A meta-analysis of observational studies. European Endocrinology Journal. 18 citations.

  4. Anagnostis, P., Gkekas, N., Artzouchaltzi, A. M., Kosmidou, N., Siolos, P., & Potoupnis, M. (2019). Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: A systematic review and meta-analysis. Journal of Clinical Endocrinology. 35 citations.

  5. Anagnostis, P., Selalmatzidou, D., Polyzos, S. A., Panagiotou, A., Slavakis, A., Panagiotidou, A., Athyros, V. G., Karagiannis, A., & Mikhailidis, D. P. (2011). Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: A prospective randomized study. Clinical Endocrinology. 27 citations.

  6. Anagnostis, P., Athyros, V. G., Kargiotis, K., Pagourelias, E. D., & Theocharidou, E. (2010). Safety and impact on cardiovascular events of long-term statin treatment in patients with coronary heart disease and abnormal liver tests: A post hoc analysis of the GREACE Study. Hellenic Journal of Cardiology. 22 citations.

  7. Anagnostis, P., D. Selalmatzidou, Efstathiadou, Z. A., Katergari, S., Poulasouchidou, M., Slavakis, A., & Kita, M. (2012). The effect of L-thyroxine substitution on lipid profile, glucose homeostasis, and coagulation in patients with subclinical hyperthyroidism. Hellenic Journal of Endocrinology. 19 citations.